Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Contribution of EAE to understanding and treating multiple sclerosis.
Lipopolysaccharide Binding Protein and Oxidative Stress in a Multiple Sclerosis Model.
Enantioselective total synthesis of the highly selective sphingosine-1-receptor VPC01091 by the Heck desymmetrization of a non-activated cyclopentene-fused spiro-pyrrolidinone.
Progressive multifocal leukoencephalopathy in a patient without apparent immunosuppression.
Cerebral Microbleeds in Multiple Sclerosis Evaluated on Susceptibility-weighted Images and Quantitative Susceptibility Maps: A Case-Control Study.
Factitious Graves' disease due to biotin immunoassay interference - A case and review of the literature.
Predictors of the 10-year direct costs for treating multiple sclerosis.
Insulin influenced expression of myelin proteins in diabetic peripheral neuropathy.
Two - Dimensional Potentials of Mean Force of Nile Red in Intact and Damaged Model Bilayers. Application to Calculations of Fluorescence Spectra.
Germinoma Mimicking Tumefactive Demyelinating Disease in Pediatric Patients.
High-dose erythropoietin in patients with progressive multiple sclerosis: A randomized, placebo-controlled, phase 2 trial.
[Role of nurses in the managements of symptoms associated with spasticity in patients with multiple sclerosis].
Proof of Principle: Coronin 1A - An Intrinsic Modulator of T Lymphocyte Function.
Sphingosine-1-phosphate modulators in inflammatory skin diseases-Lining up for clinical translation.
Association of CD40 Gene Polymorphisms with Susceptibility to Neuromyelitis Optica Spectrum Disorders.
Children with multiple sclerosis should not become therapeutic hostages.
Fluctuations of spontaneous EEG topographies predict disease state in relapsing-remitting multiple sclerosis.
How long does it take to diagnose patients with neuromyelitis optica (NMO) using the 2006 diagnostic criteria?
Righting Reflex Predicts Long-Term Histological and Behavioral Outcomes in a Closed Head Model of Traumatic Brain Injury.
Ongoing increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: A 50-year study.
Acute disseminated encephalomyelitis following Plasmodium vivax malaria.
Comparison of serum Concentration of Se, Pb, Mg, Cu, Zn, between MS patients and healthy controls.
Dysregulation of Chemokine/Chemokine Receptor Axes and NK Cell Tissue Localization during Diseases.
HLA Genetic Risk Burden in Multiple Sclerosis.
Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis.
Pages
« first
‹ previous
…
836
837
838
839
840
841
842
843
844
…
next ›
last »